Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001012975-25-000775·ARCH Venture Fund VII, L.P.
Schedule 13G ownership disclosure
UNITY BIOTECHNOLOGY INC
Common Stock, par value $0.0001 per share · CUSIP: 91381U200
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ARCH Venture Fund VII, L.P.
Shares: 0 · Class: 0%
- ARCH Venture Fund VIII Overage, L.P.
Shares: 0 · Class: 0%
- ARCH Venture Partners VII, L.P.
Shares: 0 · Class: 0%
- ARCH Venture Partners VII, LLC
Shares: 0 · Class: 0%
- ARCH Venture Partners VIII, LLC
Shares: 0 · Class: 0%
- Keith Crandell
Shares: 0 · Class: 0%
- Clinton Bybee
Shares: 0 · Class: 0%
- Robert Nelsen
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001012975-25-000775
- Form type
- SCHEDULE 13G/A
- Filer
- ARCH Venture Fund VII, L.P.
- CIK
- CIK 1402439
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership